Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1652 (Showing 81 to 100) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. Lauren King NCI-DCEG PLCO Jan 30, 2020 PLCO-576
Use of Tobacco Biomarkers in Lung Cancer Risk Assessment Christine Lambert University of Minnesota PLCO Jan 30, 2020 PLCO-563
Prostate cancer risk prediction using clinical risk factors and genetics Renee George Multimodal Imaging Services Corporation, dba HealthLytix PLCO Jan 30, 2020 PLCO-574
Comparison of National Lung Cancer Resection Outcomes to Screening Trial Outcomes Tyler Grenda Sidney Kimmel Medical College, Thomas Jefferson University NLST Jan 27, 2020 NLST-633
Lung cancer detection using Deep Convolutional Neural Network Deepa P L Mar Baselios College of Engineering and Technology NLST Jan 27, 2020 NLST-632
Improvement of the Accuracy in Detection of pulmonary nodules Wei-Ying Chen International Integrated Systems, Inc NLST Jan 27, 2020 NLST-631
Studies to use extended NLST follow-up data Hormuzd Katki NCI NLST Jan 27, 2020 NLST-626
Targeting low-dose computer tomography screening to improve lung-cancer survival: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the National Lung Screening Trial Liangyuan Hu Icahn School of Medicine NLST Jan 27, 2020 NLST-630
Data-efficient and interpretable machine learning framework for lung cancer screening Lei Xing Stanford University NLST Jan 27, 2020 NLST-628
Identification of High-Risk Cohorts using PLCO data for Targeted Gastric Cancer Prevention and Control Strategies Haejin In Albert Einstein College of Medicine PLCO Jan 27, 2020 PLCO-567
Uncovering roles of polyunsaturated fatty acids (PUFA) in pancreatic cancer etiology: a gene-diet interaction study Lang Wu University of Hawaii at Manoa PLCO Jan 27, 2020 PLCO-573
Dietary fiber, whole grains and risk of hepatocellular carcinoma Katherine McGlynn National Cancer Institute PLCO Jan 27, 2020 PLCO-554
Development of a machine learning algorithm for generating realistic synthetic electronic healthcare records (Prosate and Breast) Andreas Maier FAU Erlangen N├╝rnberg PLCO Jan 27, 2020 PLCO-570
Cell Free DNA Methylome for Lung Cancer Early Detection Rayjean Hung Sinai Health System PLCO Jan 23, 2020 2019-1024
Cell Free DNA Methylome for Pancreatic Cancer Early Detection Rayjean Hung Sinai Health System PLCO Jan 23, 2020 2019-1023
Exascale Deep Learning for Predictive Modeling of Lung Cancer Greeshma Agasthya Oak Ridge National Laboratory NLST Jan 22, 2020 NLST-586
Identification of lung cancer using machine learning and image processing Hossein Safari University of Zanjan NLST Jan 14, 2020 NLST-583
Development of lung cancer diagnostic artificial intelligence based on CT images Mate Denes Ulyssys Ltd. NLST Jan 10, 2020 NLST-627
Helicobacter pylori strain-specific blood biomarker and lung cancer risk Qiuyin Cai Vanderbilt University Medical Center PLCO Jan 10, 2020 2019-1026
Total antioxidant capacity and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Zhong Guo-Chao The Second Affiliated Hospital of Chongqing Medical University PLCO Jan 8, 2020 PLCO-565